On May 15, 2025, a delegation led by Mr. Lü Heping, Assistant General Manager of Genertec China Medicine, visited chihealbio for an exchange meeting. Dr. Zhang Zhefeng, Chairman of chihealbio, along with the company’s leadership team, warmly received the guests.

The Genertec China Medicine delegation first toured chihealbio’s Molecular Design Institute, Artificial Intelligence Center, and Long-Acting Peptide Technology Platform. Subsequently, the two parties engaged in in-depth discussions on multiple projects, including GLP-1 triple-target peptides, innovative oral small-molecule drugs, muscle-preserving weight-loss therapies, CNS (central nervous system) innovative drugs, industrial-scale liposomes, and nanoformulations. Together, they explored new opportunities for strategic collaboration. This visit further strengthened the strategic partnership between the two companies in the pharmaceutical and healthcare sectors, laying a solid foundation for future synergistic development.

Moving forward, chihealbio will maintain close communication with Genertec China Medicine to refine cooperation plans and advance the practical implementation of projects. Together, the two companies aim to inject new momentum into the high-quality development of the pharmaceutical industry.

This visit and exchange aimed to deepen the strategic collaboration between chihealbio and Genertec China Medicine. By integrating resources and leveraging complementary strengths, the two parties seek to jointly drive technological innovation and industrial upgrading, paving the way for a new chapter of synergistic and high-quality development in the pharmaceutical and healthcare fields.